Cytotoxic effects of Shiga toxin type 2 and its B subunit on human renal tubular epithelial cell cultures;Efecto citotoxico de la toxina shiga tipo 2 y su subunidad b en celulas epiteliales tubulares renales humanas en cultivo

Medicina

Volumn 65, Issue 2, 2005, Pages 147-150

  Pistone Creydt, Virginia ^a   Nuñez, Pablo ^a   Zotta, Elsa ^a   Ibarra, Cristina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Hemolytic uremic syndrome; Renal failure; Shiga toxin

Indexed keywords

BUTYRIC ACID; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PROTEIN SUBUNIT; VEROTOXIN 2; WATER; SHIGA TOXIN 2 B SUBUNIT;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; ESCHERICHIA COLI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; KIDNEY FAILURE; KIDNEY TUBULE EPITHELIUM; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; ADULT; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; HEMOLYTIC UREMIC SYNDROME; KIDNEY TUBULE; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; EPITHELIAL CELLS; ESCHERICHIA COLI; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY FAILURE; KIDNEY TUBULES; PROTEIN SUBUNITS; SHIGA-LIKE TOXIN II;

EID: 19744371597     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET: The hemolytic uremic syndrome. Neprhon 1973; 11: 174-92.
2. Ferraris JR, Ramirez JA, Ruiz S, et al: Shiga toxin-associated hemolytic uremic syndrome: absence of recurence after renal transplantation. Pediatr Nephrol 2002; 17: 809-14.
3. Comité de Nefrología: Incidencia del Síndrome Urémico Hemolítico (SUH) en la República Argentina. Arch Arg Pediatría 1995; 93: 407-11.
4. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI: The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. New Engl J Med 2000; 342: 1930-6.
5. Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT: Pathogenesis of Shigella diarrhea: XVII. A mammalian-cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J Infect Dis 1986; 169: 538-46.
6. Sandvig K and Van Deurs B: Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol Rev 1996; 76: 949-66.
7. Taguchi T, Uchida H, Kiyokawa N, et al: Verotoxins induce apoptosis in human renal tubular epithelium derived. Kidney Int 1998; 53: 1681-8.
8. Marcato P, Mulvey G, Armstrong GD: Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells. Infect Immun 2002; 70: 1279-86.
9. Karpman D, Andreasson A, Thysell H, Kaplan BS, Svanborg C: Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatr Nephrol 1995; 9: 694-9.
10. Karpman D, Hakansson A, Perez MT, et al: Apoptosis of renal cortical cells in the hemolitic-uremic syndrome: in vivo and in vitro studies. Infect Immun 1997; 66: 636-44.
11. Kiyokawa N, Taguchi T, Mori T, et al: Induction of apoptosis in normal renal tubular epithelial cells by Escherichia coli shiga toxin 1 and 2. J Infect Dis 1998; 178: 178-84.
12. Cherla RP, Sang-Yun L, Tesh VL: Shiga toxins and apoptosis. FEMS Microbiol Lett 2003; 228: 159-66.
13. Pistone Creydt V, Miyakawa MF, Martin F, Zotta E, Silberstein C, Ibarra C: The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops. Braz J Med Biol Res 2004; 37: 799-808.
14. Dorr RA, Kierbel A, Vera J, Parisi M: A new data-acquisition system for the measurement of the net water flux across apithelia. Comput Methods Programs Biomed 1997; 53: 9-14.
15. Yamasaki Ch, Nishikawa K, Zeng XT, et al: Induction of cytokines by toxins that an identical RNA N-glycosidase activity: Shiga toxin, ricin, and modeccin. Biochimica et Biophysica Acta 2004; 1671: 44-50.
16. Haicheur N, Bismuth E, Bosset S, et al: The B subunit of Shiga toxin to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J Immunol 2000; 165: 3301-8.